Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
National Institutes of Health · National Cancer Institute · +4 more institutions
Abstract
Monoclonal gammopathy of undetermined significance (MGUS) is a premalignant plasma-cell proliferative disorder associated with a life-long risk of progression to multiple myeloma (MM). It is not known whether MM is always preceded by a premalignant asymptomatic MGUS stage. Among 77,469 healthy adults enrolled in the nationwide population-based prospective Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial, we identified 71 subjects who developed MM during the course of the study in whom serially collected (up to 6) prediagnostic serum samples obtained 2 to 9.8 years prior to MM diagnosis were available. Using assays for monoclonal (M)-proteins (electrophoresis/immunofixation) and…
Citation impact
- FWCI
- 31.34
- Percentile
- 100%
- References
- 25
Authors
12- OLOla LandgrenCorresponding
National Institutes of Health, National Cancer Institute, Cancer Genetics (United States), Center for Cancer Research, Division of Cancer Epidemiology and Genetics
- RARobert A. Kyle
Mayo Clinic in Arizona
- RMRuth M. Pfeiffer
Cancer Genetics (United States), Division of Cancer Epidemiology and Genetics
- JAJerry A. Katzmann
Mayo Clinic in Arizona
- NENeil E. Caporaso
Cancer Genetics (United States), Division of Cancer Epidemiology and Genetics
Topics & keywords
- Monoclonal gammopathy of undetermined significance
- Medicine
- Serum protein electrophoresis
- Asymptomatic
- Multiple myeloma
- Internal medicine
- Gastroenterology
- Immunofixation
- Good health and well-being